DISCOVERY: a study examining the prevalence of transthyretin mutations in subjects suspected of having cardiac amyloidosis

por Akinboboye, Olakunle, Ananthasubramaniam, Karthik, Malik, Amir, Warner, Alberta, Karsten, Verena, Damy, Thibaud, Taylor, Herman A, Maurer, Mathew S
Publicado 2015

The Protozoan Parasite Toxoplasma gondii Targets Proteins to Dense Granules and the Vacuolar Space Using Both Conserved and Unusual Mechanisms

por Karsten, Verena, Qi, Huilin, Beckers, Con J.M., Reddy, Anita, Dubremetz, Jean-Francois, Webster, Paul, Joiner, Keith A.
Publicado 1998

msbB deletion confers acute sensitivity to CO(2 )in Salmonella enterica serovar Typhimurium that can be suppressed by a loss-of-function mutation in zwf

por Karsten, Verena, Murray, Sean R, Pike, Jeremy, Troy, Kimberly, Ittensohn, Martina, Kondradzhyan, Manvel, Low, K Brooks, Bermudes, David
Publicado 2009

Analysis of disease progression in patients with transthyretin cardiac amyloidosis

por Gilmore, Julian D, Maurer, Mathew S, Vest, John, Karsten, Verena, Powell, Christine, Strahs, Andrew, Gollob, Jared, Hawkins, Philip N
Publicado 2015

Phase 2, open-label extension (OLE) study of revusiran, an investigational RNAi therapeutic for the treatment of patients with transthyretin cardiac amyloidosis

por Gillmore, Julian D, Falk, Rodney H, Maurer, Mathew S, Hanna, Mazen, Karsten, Verena, Vest, John, Gollob, Jared, Hawkins, Philip N
Publicado 2015

Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)

por Judge, Daniel P., Kristen, Arnt V., Grogan, Martha, Maurer, Mathew S., Falk, Rodney H., Hanna, Mazen, Gillmore, Julian, Garg, Pushkal, Vaishnaw, Akshay K., Harrop, Jamie, Powell, Christine, Karsten, Verena, Zhang, Xiaoping, Sweetser, Marianne T., Vest, John, Hawkins, Philip N.
Publicado 2020